Offner; Sonja
Patent Applications and Registrations
Patent applications and USPTO patent grants for Offner; Sonja.The latest application filed is for "anti-rabbit cd19 antibodies and methods of use".
- Offner; Sonja - Penzberg DE
- Offner; Sonja - Munich DE
| Patent | Date |
|---|---|
| Anti-rabbit Cd19 Antibodies And Methods Of Use App 20220135672 - Haas; Alexander ; et al. | 2022-05-05 |
| B-cell Cultivation Method App 20210123019 - Offner; Sonja ; et al. | 2021-04-29 |
| Single B-cell Cultivation Method App 20210062149 - ENDL; Josef ; et al. | 2021-03-04 |
| B-cell cultivation method Grant 10,889,802 - Offner , et al. January 12, 2 | 2021-01-12 |
| B-cell Cultivation Method App 20200399596 - OFFNER; Sonja ; et al. | 2020-12-24 |
| Antibodies Binding To Human And Cynomolgus Cd3 Epsilon App 20200325224 - Tiefenthaler; Georg ; et al. | 2020-10-15 |
| Antibodies Binding To Human And Cynomolgus Cd3 Epsilon App 20200299385 - Tiefenthaler; Georg ; et al. | 2020-09-24 |
| Method For The Production Of Thymocyte Supernatant App 20200165566 - OFFNER; Sonja ; et al. | 2020-05-28 |
| Assay And Method For Determining Cdc Eliciting Antibodies App 20190241661 - Dengl; Stefan ; et al. | 2019-08-08 |
| Cd40l Expressing Mammalian Cells And Their Use App 20190153091 - Endl; Josef ; et al. | 2019-05-23 |
| B-cell Cultivation Method App 20190017022 - Offner; Sonja ; et al. | 2019-01-17 |
| Single B-cell Cultivation Method App 20180298335 - Endl; Josef ; et al. | 2018-10-18 |
| Assay And Method For Determining Cdc Eliciting Antibodies App 20180017572 - Offner; Sonja ; et al. | 2018-01-18 |
| Antibodies Binding To Human And Cynomolgus Cd3 Epsilon App 20170233475 - Tiefenthaler; Georg ; et al. | 2017-08-17 |
| Single B-cell Cultivation Method App 20160251621 - Endl; Josef ; et al. | 2016-09-01 |
| Antibodies against human IL33R and uses thereof Grant 9,309,319 - Fertig , et al. April 12, 2 | 2016-04-12 |
| Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 9,290,567 - Bohrmann , et al. March 22, 2 | 2016-03-22 |
| Cd40l Expressing Mammalian Cells And Their Use App 20140315252 - Endl; Josef ; et al. | 2014-10-23 |
| Antibodies Against Human Il33r And Uses Thereof App 20140302015 - Fertig; Georg ; et al. | 2014-10-09 |
| Pharmaceutical composition comprising a bispecific antibody for EpCAM Grant 8,790,645 - Kufer , et al. July 29, 2 | 2014-07-29 |
| Antibodies against human IL33R and uses thereof Grant 8,785,153 - Fertig , et al. July 22, 2 | 2014-07-22 |
| Use of an anti-Tau pS422 antibody for the treatment of brain diseases Grant 8,609,097 - Bohrmann , et al. December 17, 2 | 2013-12-17 |
| Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20130310541 - Bohrmann; Bernd ; et al. | 2013-11-21 |
| Single B-cell Cultivation Method App 20130084637 - Endl; Josef ; et al. | 2013-04-04 |
| Antibodies against human IL33R and uses thereof App 20120213774 - Fertig; Georg ; et al. | 2012-08-23 |
| Pharmaceutical Composition Comprising A Bispecific Antibody For Epcam App 20110256137 - Kufer; Peter ; et al. | 2011-10-20 |
| Pharmaceutical composition comprising a bispecific antibody for EpCAM Grant 7,919,089 - Kufer , et al. April 5, 2 | 2011-04-05 |
| Use Of An Anti-tau Ps422 Antibody For The Treatment Of Brain Diseases App 20110059093 - Bohrmann; Bernd ; et al. | 2011-03-10 |
| Pharmaceutical composition comprising a bispecific antibody for epcam App 20070081993 - Kufer; Peter ; et al. | 2007-04-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 